Register Today

2026 Congressional Briefing Hosted by Dr. Rahul Gupta, former Director of National Drug Control Policy

Join for a briefing on FDA Scheduling Recommendation of 7OH, DEA Action, Clarity of Kratom, and Consumer Protection Legislation

Date: June 3rd
Time:‍ ‍11 am
Location:Capitol Visitor Center – HVC 201

Members of Congress, staff, stakeholders and Media Members are encourage to attend a special Congressional Briefing on kratom legislation and recent related activity.

Gain a better understand of kratom science and policy, as well as the HHS and FDA scheduling recommendation on 7-Hydroxymitragynine (7OH) and the threat to Americans of synthetic products posing as natural kratom.This important briefing will:

• Clarify the distinction between kratom and concentrated 7OH products.

• Explain how the Federal Kratom Consumer Protection Act will complement FDA and DEA activity, close regulatory gaps, and ensure robust consumer protections.

• Provide scientific and policy context to a complex and nuanced issue that impacts millions of American consumers.

Expert presenters will share how this balanced framework ensures public safety while respecting consumer access to natural kratom products.

Please register and join us for this timely and informative discussion.